● The stock, which is currently worth 2019 to 0.71 times its sales, is clearly overvalued in comparison with peers.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The stock is in a well-established, long-term rising trend above the technical support level at 9.78 USD
Weaknesses
● Stock prices approach a strong long-term resistance in weekly data at USD 14.24.
● The stock is close to a major daily resistance at USD 14.6, which should be gotten rid of so as to gain new appreciation potential.
● According to forecast, a sluggish sales growth is expected for the next fiscal years.
● The company has insufficient levels of profitability.
● The group shows a rather high level of debt in proportion to its EBITDA.
● The group usually releases earnings worse than estimated.
● The firm trades with high earnings multiples: 29.82 times its 2019 earnings per share.
● Revenue estimates are regularly revised downwards for the current and coming years.
● For the past seven days, analysts have been lowering their EPS expectations for the company.
● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
● For the past year, analysts have significantly revised downwards their profit estimates.